Relationship Between Four Non-Insulin-Based Indexes of Insulin Resistance and Serum Uric Acid in Patients with Type 2 Diabetes: A Cross-Sectional Study

Overview

Journal Diabetes Metab Syndr Obes

Publisher Dove Medical Press

Specialty Endocrinology

Date 2022 May 20

PMID 35591906

Authors

Rongfeng Han

Yang Zhang

Xia Jiang

Affiliations

Soon will be listed here.

Abstract

Aim: The aim of this study was to investigate the association between serum uric acid (SUA) levels and four insulin resistance surrogates in patients with type 2 diabetes (T2DM). The four non-insulin-based indexes of insulin resistance (IR) include the glucose and triglycerides index (TyG), TyG index with body mass index (TyG-BMI), ratio of triglycerides to high-density lipoprotein cholesterol (TG/HDL-c) and metabolic score for insulin resistance (METS-IR).

Methods: A total of 687 patients with T2DM were enrolled in the current study. Patients were stratified into three groups according to their levels of SUA. Spearman correlation was used to analyze the correlation between SUA and clinical variables. Multiple linear regression analysis was used to assess the association between SUA and the four insulin resistance surrogates. Receiver operating characteristic (ROC) analyses and the area under the ROC curve (AUC) were then used to assess the ability of TyG, TyG-BMI, TG/HDL-c, and METS-IR to discriminate hyperuricemia (HUA) in T2DM.

Results: SUA in T2DM was significantly positively correlated with TyG (r 0.406 P < 0.01), TyG-BMI (r 0.272 P < 0.01), TG/HDL-c (r 0.493 P < 0.01), and METS-IR (r 0.238 P < 0.01). Furthermore, higher values of the four insulin resistance surrogates were independently correlated with higher SUA levels in T2DM patients (P < 0.01 for all) after adjusting for confounding factors. TyG, TyG-BMI, TG/HDL-c, and METS-IR all had a significant discriminative ability for HUA in patients with T2DM. The AUC values were 0.693 (95% CI 0.645-0.741), 0.649 (95% CI 0.599-0.699), 0.768 (95% CI 0.726-0.811), and 0.660 (95% CI 0.609-0.710), respectively.

Conclusion: The present study suggests that TyG, TyG-BMI, TG/HDL-c and METS-IR had a significant correlation with SUA in T2DM. TG/HDL-c was the best marker among the four insulin resistance surrogates for the identification of HUA in T2DM.

Citing Articles

Association between the triglyceride/high-density lipoprotein (TG/HDL) ratio and incidence of gout: A nationwide cohort study.

Chang Y, Park J, Song T Front Endocrinol (Lausanne). 2025; 15:1453458.

PMID: 39866735 PMC: 11757121. DOI: 10.3389/fendo.2024.1453458.

Association Between Serum Uric Acid to Creatinine Ratio and Metabolic-Associated Fatty Liver Disease in Southeast China (TyG-BMI as a Potential Mediator).

Chen B, Peng X Diabetes Metab Syndr Obes. 2024; 17:4711-4720.

PMID: 39678226 PMC: 11638475. DOI: 10.2147/DMSO.S489692.

Serum uric acid and nonalcoholic fatty liver disease.

Fan J, Wang D Front Endocrinol (Lausanne). 2024; 15():1455132.

PMID: 39669496 PMC: 11635646. DOI: 10.3389/fendo.2024.1455132.

Association and Diagnostic Value of TyG-BMI for Hyperuricemia in Patients with Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study.

Li H, Gao G, Xu Z, Zhao L, Xing Y, He J Diabetes Metab Syndr Obes. 2024; 17:4663-4673.

PMID: 39660342 PMC: 11629673. DOI: 10.2147/DMSO.S484045.

Construction of a nomogram for early diagnosis of refractory pneumonia in children.

Shen W, Sun X Transl Pediatr. 2024; 13(7):1119-1129.

PMID: 39144443 PMC: 11320014. DOI: 10.21037/tp-24-16.

References

Mallat S, Al Kattar S, Tanios B, Jurjus A . Hyperuricemia, Hypertension, and Chronic Kidney Disease: an Emerging Association. Curr Hypertens Rep. 2016; 18(10):74. DOI: 10.1007/s11906-016-0684-z. View

Matsuura F, Yamashita S, Nakamura T, Nishida M, Nozaki S, Funahashi T . Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism. 1998; 47(8):929-33. DOI: 10.1016/s0026-0495(98)90346-8. View

Yu X, Wang L, Zhang W, Ming J, Jia A, Xu S . Fasting triglycerides and glucose index is more suitable for the identification of metabolically unhealthy individuals in the Chinese adult population: A nationwide study. J Diabetes Investig. 2018; 10(4):1050-1058. PMC: 6626942. DOI: 10.1111/jdi.12975. View

Martinez-Sanchez F, Vargas-Abonce V, Guerrero-Castillo A, Santos-Villavicencio M, Eseiza-Acevedo J, Meza-Arana C . Serum Uric Acid concentration is associated with insulin resistance and impaired insulin secretion in adults at risk for Type 2 Diabetes. Prim Care Diabetes. 2020; 15(2):293-299. DOI: 10.1016/j.pcd.2020.10.006. View

Caliceti C, Calabria D, Roda A, Cicero A . Fructose Intake, Serum Uric Acid, and Cardiometabolic Disorders: A Critical Review. Nutrients. 2017; 9(4). PMC: 5409734. DOI: 10.3390/nu9040395. View

Cicero A, Fogacci F, Giovannini M, Grandi E, DAddato S, Borghi C . Interaction between low-density lipoprotein-cholesterolaemia, serum uric level and incident hypertension: data from the Brisighella Heart Study. J Hypertens. 2019; 37(4):728-731. DOI: 10.1097/HJH.0000000000001927. View

White J, Sofat R, Hemani G, Shah T, Engmann J, Dale C . Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis. Lancet Diabetes Endocrinol. 2016; 4(4):327-36. PMC: 4805857. DOI: 10.1016/S2213-8587(15)00386-1. View

Sheu W, Chan S, Matawaran B, Deerochanawong C, Mithal A, Chan J . Use of SGLT-2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Abdominal Obesity: An Asian Perspective and Expert Recommendations. Diabetes Metab J. 2020; 44(1):11-32. PMC: 7043991. DOI: 10.4093/dmj.2019.0208. View

Borai A, Livingstone C, Kaddam I, Ferns G . Selection of the appropriate method for the assessment of insulin resistance. BMC Med Res Methodol. 2011; 11:158. PMC: 3258205. DOI: 10.1186/1471-2288-11-158. View

10.

Blendea M, Jacobs D, Stump C, McFarlane S, Ogrin C, Bahtyiar G . Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression. Am J Physiol Endocrinol Metab. 2004; 288(2):E353-9. DOI: 10.1152/ajpendo.00402.2004. View

11.

Abbasi F, Reaven G . Comparison of two methods using plasma triglyceride concentration as a surrogate estimate of insulin action in nondiabetic subjects: triglycerides × glucose versus triglyceride/high-density lipoprotein cholesterol. Metabolism. 2011; 60(12):1673-6. DOI: 10.1016/j.metabol.2011.04.006. View

12.

King C, Lanaspa M, Jensen T, Tolan D, Sanchez-Lozada L, Johnson R . Uric Acid as a Cause of the Metabolic Syndrome. Contrib Nephrol. 2018; 192:88-102. DOI: 10.1159/000484283. View

13.

Bjelakovic B, Stefanutti C, Bonic D, Vukovic V, Kavaric N, Saranac L . Serum uric acid and left ventricular geometry pattern in obese children. Atheroscler Suppl. 2019; 40:88-93. DOI: 10.1016/j.atherosclerosissup.2019.08.035. View

14.

Rudvik A, Mansson M . Evaluation of surrogate measures of insulin sensitivity - correlation with gold standard is not enough. BMC Med Res Methodol. 2018; 18(1):64. PMC: 6019831. DOI: 10.1186/s12874-018-0521-y. View

15.

Yuan H, Yang X, Shi X, Tian R, Zhao Z . Association of serum uric acid with different levels of glucose and related factors. Chin Med J (Engl). 2011; 124(10):1443-8. View

16.

Simental-Mendia L, Rodriguez-Moran M, Guerrero-Romero F . The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008; 6(4):299-304. DOI: 10.1089/met.2008.0034. View

17.

Bardin T, Richette P . Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC Med. 2017; 15(1):123. PMC: 5494879. DOI: 10.1186/s12916-017-0890-9. View

18.

Klisic A, Kavaric N, Ninic A . Predictive Values of Serum Uric Acid and Alanine-aminotransferase for Fatty Liver Index in Montenegrin Population. J Med Biochem. 2019; 38(4):407-417. PMC: 6708301. DOI: 10.2478/jomb-2019-0001. View

19.

Shulman G . Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med. 2014; 371(12):1131-41. DOI: 10.1056/NEJMra1011035. View

20.

Balakumar P, Maung-U K, Jagadeesh G . Prevalence and prevention of cardiovascular disease and diabetes mellitus. Pharmacol Res. 2016; 113(Pt A):600-609. DOI: 10.1016/j.phrs.2016.09.040. View